Literature DB >> 8346980

Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever.

J M Valtonen1, S Koskimies, A Miettinen, V V Valtonen.   

Abstract

OBJECTIVES: The purpose of this study was to analyse retrospectively adult patients with acute joint or muscle symptoms and a high antistreptolysin O (ASO) titre to find out which syndromes of clinical arthritis are associated with serological evidence of streptococcal infection.
METHODS: Seventy six adult patients with an acute arthritis syndrome or an exacerbation in their chronic rheumatic disease and simultaneously a high ASO titre (> or = 500 Todd units) were examined in two time periods in the 1980s.
RESULTS: Twenty six patients had arthritis associated with a known rheumatic disease, 25 had non-specific arthralgia/myalgia, 20 had reactive arthritis, and five had septic arthritis. No case of classic rheumatic fever classified by two major criteria was found. Six patients fulfilled one major and at least two minor criteria. The frequency of HLA-B27 was significantly higher in the whole patient group than in the healthy Finnish population (30 v 14%).
CONCLUSIONS: It is concluded that classic rheumatic fever is now rare, even in patients with arthritis with a high ASO titre. These results support the suggestion that beta haemolytic streptococci may trigger reactive arthritis as well as rheumatic fever.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346980      PMCID: PMC1005092          DOI: 10.1136/ard.52.7.527

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa.

Authors:  C W Fink
Journal:  J Rheumatol Suppl       Date:  1991-04

Review 2.  Group A streptococcal infections and acute rheumatic fever.

Authors:  A L Bisno
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

3.  Reactive arthritis complicating group G streptococcal septicaemia.

Authors:  S J Rogerson; N J Beeching
Journal:  J Infect       Date:  1990-03       Impact factor: 6.072

Review 4.  Reactive arthritis.

Authors:  C W Fink
Journal:  Pediatr Infect Dis J       Date:  1988-01       Impact factor: 2.129

5.  Possible role of streptococci in pathogenesis of ankylosing spondylitis.

Authors:  A C Dwivedy; A K Kapoor; A K Gupta; L M Bahuguna; G G Sanwal
Journal:  Indian J Med Res       Date:  1988-12       Impact factor: 2.375

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  Prognosis of children with poststreptococcal reactive arthritis.

Authors:  C L De Cunto; E H Giannini; C W Fink; E J Brewer; D A Person
Journal:  Pediatr Infect Dis J       Date:  1988-10       Impact factor: 2.129

8.  HL-A27 and arthritis.

Authors:  H Isomäki; K Koota; J Martio; M Nissilä; A Tilikainen
Journal:  Ann Clin Res       Date:  1975-06

9.  Frequent association of chlamydial infection with Reiter's syndrome.

Authors:  M Kousa; P Saikku; S Richmond; A Lassus
Journal:  Sex Transm Dis       Date:  1978 Apr-Jun       Impact factor: 2.830

10.  Non-group-A streptococci in rheumatic patients and their possible significance in postinfectious rheumatism.

Authors:  J JONSSON
Journal:  Acta Rheumatol Scand       Date:  1960
View more
  2 in total

1.  Association between high antistaphylolysin and teichoic acid antibody titres with rheumatic syndromes.

Authors:  J M Valtonen; M T Syrjälä; V V Valtonen
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

2.  Risk factors of uveitis in ankylosing spondylitis: An observational study.

Authors:  Li Sun; Rui Wu; Qin Xue; Feng Wang; Peirong Lu
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.